In the previously reported chronic GVHD in humanized mice [8, 9], GVHD develops 4–5 months after transplantation of high-purity CD34-positive cells containing almost no peripheral blood T-cells, suggesting that GVHD developed by a mechanism different from that in the existing experimental mouse models. Here, CD34 is linked to graft versus host disease.